| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| QRS INTERNATIONAL Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 61,99 | 0,00 % | Can BTSG Outgrow the $20B Acute Infusion Market on Volume Growth? | ||
| ALIGNMENT HEALTHCARE | 13,030 | 0,00 % | Kaplan Fox is Investigating Possible Securities Law Violations against Alignment Healthcare, Inc. (NASDAQ: ALHC) | ||
| LIFESTANCE HEALTH GROUP | 12,595 | 0,00 % | LifeStance prices 22.3 million share secondary offering at $12.35 | ||
| GENEDX | 86,48 | 0,00 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| HEARTFLOW | 46,720 | 0,00 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| BILLIONTOONE | 99,05 | -0,11 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 14,030 | +0,07 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| PROGYNY | 27,100 | -0,07 % | Progyny auf Gesundheitskonferenz von Wells Fargo: Wachstumsperspektiven bleiben intakt | ||
| FRESENIUS | 44,715 | +1,95 % | UBS stuft Fresenius SE auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Fresenius mit einem Kursziel von 56 Euro auf "Buy" belassen. Analyst Graham Doyle hält die Sorgen um das US-Geschäft mit... ► Artikel lesen | |
| ADAPTHEALTH | 5,700 | 0,00 % | Truist reiterates Buy on AdaptHealth stock after CFO change | ||
| BETA BIONICS | 17,410 | -0,06 % | Beta Bionics, Inc.: Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance | IRVINE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,850 | +0,80 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,520 | -0,44 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers mit einem Kursziel von 50 Euro auf "Buy" belassen. Die Innovationsdynamik bleibe hoch, schrieb Julien... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 20,760 | +0,10 % | Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Seeking Recovery to Contact the Firm Before September 22, 2026 | ||
| PRIVIA HEALTH GROUP | 20,440 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen |